on 22 Jun 2021
Last Applicant/ Owned by
6F, Building C1, No. 11 Kaiyuan Road
Guangzhou
CN
511300
Serial Number
88125441 filed on 20th Sep 2018
Registration Number
6392215 registered on 22nd Jun 2021
Correspondent Address
Kevin S. Costanza
Filing Basis
1. intent to use
Disclaimer
NO DATA
Color is not claimed as a feature of the mark. The mark consists of a stylized letter "B" having an upward and forward-curving tail that terminates at a star; the letter "B" being a darker shading and the tail being a lighter shading; the letter "B" containing cross-hatching in a lighter shade. Pharmaceutical drugs for treatment of infectious diseases; Chewing gum for medical purposes; ß-blockerRead More
Pharmaceutical drugs for treatment of infectious diseases; Chewing gum for medical purposes; ß-blockers; Drugs for medical purposes, namely, valsartan; Antioxidant drugs, namely, antioxidant food supplements; Pre-filled syringes for medical purposes filled with pharmaceutical preparations, namely, pharmaceutical preparations for treating nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson's disease, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseases; Nutraceutical preparations for therapeutic or medical purposes, namely, nutraceuticals for the treatment of nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson's disease, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseases; Chemical preparations for medical purposes for the treatment of illnesses or conditions, namely, nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson's disease, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseases; Pharmaceutical preparations for the treatment of illnesses or conditions, namely, nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson's disease, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseases
No 88125441
No Service/Collective Mark
No 161107.208
No
No
No
No
No
No
No
No
01.01.02 -
A single star with four points
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of a stylized letter "B" having an upward and forward-curving tail that terminates at a star; the letter "B" being a darker shading and the tail being a lighter shading; the letter "B" containing cross-hatching in a lighter shade.
| Status Date | Action Taken |
|---|---|
| 22nd Jun 2021 | REGISTERED-PRINCIPAL REGISTER |
| 06th Apr 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 06th Apr 2021 | PUBLISHED FOR OPPOSITION |
| 17th Mar 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 04th Mar 2021 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 25th Feb 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 25th Feb 2021 | EXAMINER'S AMENDMENT ENTERED |
| 25th Feb 2021 | EXAMINERS AMENDMENT E-MAILED |
| 25th Feb 2021 | EXAMINERS AMENDMENT -WRITTEN |
| 25th Feb 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
